ClinicalTrials.gg
RecruitingNCT02374944FIRMUpdated Nov 9, 2022

Fixation Insitu Versus Removal for Midfoot Lisfranc Injuries

An interventional study of Hardware removal in Closed Fracture Dislocation, Tarsometatarsal Joint and Open Fracture Dislocation, Tarsometatarsal Joint, sponsored by University of Calgary. Recruiting at 3 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-09.

Sponsored by University of Calgary · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Jan 2018; still recruiting 8 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is a multicenter prospective randomized control trial comparing hardware retention (HR) to removal of hardware (RH).

Read the detailed description

Eligible patients will be randomized to one of two treatment arms: Hardware removal at 6 months or Hardware retention for a minimum of 2 years.

Consenting patients having previously undergone open reduction and internal fixation of Lisfranc injuries with an anatomic reconstruction within 6-8 weeks will be randomized to one of two treatment arms: removal hardware (RH) or hardware retention (HR).

Outcome will be assessed at 6 weeks, 12 weeks, 6 months, 1 year, and 2 years from enrollment.

02

Conditions studied

  • Closed Fracture Dislocation, Tarsometatarsal Joint
  • Open Fracture Dislocation, Tarsometatarsal Joint
03

In context

Fractures, Closed

44 studies on the registry are indexed under Fractures, Closed; 4 are open to participants now.

This study's planned enrollment of 94 is above the median of 45 across 34 interventional studies indexed under Fractures, Closed.

Browse Fractures, Closed studies →

Lead sponsor

University of Calgary is the lead sponsor of 703 studies on the registry; 196 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subject has Lisfranc injury that was treated within 28 days of injury.
  • Subject must be enrolled in study between 6 and 8 weeks from time of initial fixation operation.
  • The patient must be medically fit for anesthesia
  • Subject is willing and able to provide written for trial participation
  • Subject is willing and able to comply with the study protocol including return for all follow-up evaluations
  • Subject may have a bony, ligamentous, or combined lisfranc injury
  • Demonstrated instability of the lisfranc complex on static, stress view or CT radiography.
  • Associated injuries - other than the lisfranc complex - are permitted provided those injuries are not deemed to significantly influence the rehabilitation or recovery of the patient at the discretion of the enrolling surgeon
  • Adequate reduction to within 1mm of lisfranc complex at time of fixation
  • Hardware across the midfoot (tarsal-metatarsal joints 1-3)

Exclusion criteria

Exclusion Criteria:

  • Subject has a significant pre-existing foot injury
  • Subject has a delay in initial treatment greater than 28 days from time of injury
  • Subject has an active infection in the area of surgical approach requiring surgical debridement
  • Subject has concomitant injury which, in the opinion of the attending surgeon, is likely to impair rehabilitation or prolong fracture healing time (another long bone fracture, ipsilateral limb injury)
  • Subject has a history of rheumatoid arthritis, Diabetes, fibrous dysplasia, chronic renal failure, Paget's disease, or osteopetrosis or any other pre-existing pathologic condition affecting the Lisfranc complex
  • Subject has a high risk of death from surgery ( Class V)
  • Subject is likely unable to maintain follow-up(no fixed address, plans to move out of town in the next year, states unable to comply with protocol, etc.)
  • Subject has cognitive impairment or language difficulties that would impede the valid completion of questionnaires
  • Subject is pregnant
  • There has been loss of fixation or reduction prior to enrollment
  • Previous corrective foot surgery
  • Associated fracture of calcaneus, talus, or tibial plafond.
  • Pathologic fracture
  • Loss of fixation or reduction prior to enrollment
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
94 participants (estimated)

Study arms

  • Experimental
    Hardware Removal

    Removal of hardware at 6 months.

    Procedure: Hardware removal

  • No intervention
    Hardware Retention

    Retention of hardware at 6 months

Interventions

  • ProcedureHardware removal

    Comparison of implant retention vs. scheduled implant removal in skeletally mature patients with previously operatively treated Lisfranc injuries requiring screw and/or plate fixation.

06

What researchers measure

Primary outcomes

  1. AOFAS - American Orthopaedic Foot and Ankle Society Midfoot Score

    Subjective and objective evaluation of the midfoot with breakdown by function (45 points), pain (40 points), and alignment (15 points) with a yield anywhere between 0 and 100 points where 100 points is a perfect score.

    Time frame: 6 weeks

  2. AOFAS - American Orthopaedic Foot and Ankle Society Midfoot Score

    Subjective and objective evaluation of the midfoot with breakdown by function (45 points), pain (40 points), and alignment (15 points) with a yield anywhere between 0 and 100 points where 100 points is a perfect score.

    Time frame: 12 weeks

  3. AOFAS - American Orthopaedic Foot and Ankle Society Midfoot Score

    Subjective and objective evaluation of the midfoot with breakdown by function (45 points), pain (40 points), and alignment (15 points) with a yield anywhere between 0 and 100 points where 100 points is a perfect score.

    Time frame: 6 months

  4. AOFAS - American Orthopaedic Foot and Ankle Society Midfoot Score

    Subjective and objective evaluation of the midfoot with breakdown by function (45 points), pain (40 points), and alignment (15 points) with a yield anywhere between 0 and 100 points where 100 points is a perfect score.

    Time frame: 1 year

  5. AOFAS - American Orthopaedic Foot and Ankle Society Midfoot Score

    Subjective and objective evaluation of the midfoot with breakdown by function (45 points), pain (40 points), and alignment (15 points) with a yield anywhere between 0 and 100 points where 100 points is a perfect score.

    Time frame: 2 years

  6. VAS-FA - Visual Analog Scale Foot and Ankle

    Patient reported responses on 20 subjective questions (Pain - 4; functional deficits -13; other complaints - 3) equally weighted. Possible score out of 100.

    Time frame: 6 weeks

  7. VAS-FA - Visual Analog Scale Foot and Ankle

    Patient reported responses on 20 subjective questions (Pain - 4; functional deficits -13; other complaints - 3) equally weighted. Possible score out of 100.

    Time frame: 12 weeks

  8. VAS-FA - Visual Analog Scale Foot and Ankle

    Patient reported responses on 20 subjective questions (Pain - 4; functional deficits -13; other complaints - 3) equally weighted. Possible score out of 100.

    Time frame: 6 months

  9. VAS-FA - Visual Analog Scale Foot and Ankle

    Patient reported responses on 20 subjective questions (Pain - 4; functional deficits -13; other complaints - 3) equally weighted. Possible score out of 100.

    Time frame: 1 year

  10. VAS-FA - Visual Analog Scale Foot and Ankle

    Patient reported responses on 20 subjective questions (Pain - 4; functional deficits -13; other complaints - 3) equally weighted. Possible score out of 100.

    Time frame: 2 years

  11. SF-36

    Patient reported measure on physical and mental status on 36 items across eight health domains.

    Time frame: 6 weeks

  12. SF-36

    Patient reported measure on physical and mental status on 36 items across eight health domains.

    Time frame: 12 weeks

  13. SF-36

    Patient reported measure on physical and mental status on 36 items across eight health domains.

    Time frame: 6 months

  14. SF-36

    Patient reported measure on physical and mental status on 36 items across eight health domains.

    Time frame: 1 year

  15. SF-36

    Patient reported measure on physical and mental status on 36 items across eight health domains.

    Time frame: 2 years

  16. VAS - Visual Analogue Scale (Patient Satisfaction)

    Single visual analogue scale to evaluate patient satisfaction on a scale of 0 to 100.

    Time frame: 6 weeks

  17. VAS - Visual Analogue Scale (Patient Satisfaction)

    Single visual analogue scale to evaluate patient satisfaction on a scale of 0 to 100.

    Time frame: 12 weeks

  18. VAS - Visual Analogue Scale (Patient Satisfaction)

    Single visual analogue scale to evaluate patient satisfaction on a scale of 0 to 100.

    Time frame: 6 months

  19. VAS - Visual Analogue Scale (Patient Satisfaction)

    Single visual analogue scale to evaluate patient satisfaction on a scale of 0 to 100.

    Time frame: 1 year

  20. VAS - Visual Analogue Scale (Patient Satisfaction)

    Single visual analogue scale to evaluate patient satisfaction on a scale of 0 to 100.

    Time frame: 2 years

Secondary outcomes

  1. Radiologic outcome

    Radiographic measurement of the gap between 1st and 2nd metatarsals and maintenance of reduction on static and weight bearing xrays from index films at enrollment to 2 years.

    Time frame: 2 years

  2. Cost-effectiveness

    Cost of treatment and complications plus incremental costs up to 2 year follow up will be collected and compared with Quality Adjusted Life Years (QALYs)

    Time frame: 2 years

07

Study locations

1 of 3 sites recruiting
  • Foothills Medical Centre
    Calgary, Alberta, Canada
    Recruiting
    • Karin Lienhard, PhD · Contactkarin.lienhard@ucalgary.ca · 4039444594
    • Paul Duffy, MD · Principal investigator
    • Robert Korley, MD · Sub investigator
    • Christopher R Martin, MD · Sub investigator
    • Richard Buckley, MD · Sub investigator
    • Prism Schneider, MD · Sub investigator
  • Peter Lougheed Centre
    Calgary, Alberta, Canada
    Active, not recruiting

    Not enrolling at this site.

  • South Health Campus
    Calgary, Alberta, Canada
    Active, not recruiting

    Not enrolling at this site.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 9, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02374944
Collaborators
Calgary Orthopaedic Research and Education Fund, Memorial University of Newfoundland
Responsible party
Paul Duffy (Division Head, Orthopaedic Trauma, University of Calgary) — Principal investigator
First posted
Mar 2, 2015
Start date
Jan 23, 2018
Primary completion
Dec 2024 (estimated)
Completion
Dec 2025 (estimated)
Last update
Nov 9, 2022

Study contacts

Karin Lienhard, PhD
Contact
karin.lienhard@ucalgary.ca
403-944-2932
Paul J Duffy, MD
principal investigator · University of Calgary

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion